Subscribe to Newsletter
Navigation
- Select Page -
Subscribe to Newsletter
3 Articles
PercayAI
PERCAYAI is reimagining the drug discovery process by through artificial intelligence software.
For more information, visit
PercayAI
or follow their updates on:
PercayAI Articles
PercayAI and Saint Louis University Partner to Accelerate AI Adoption in Biomedical Research
EQ Staff, Jonathan Allen
February 2, 2021
October 3, 2021
< 1
Min
Read
Augmented Intelligence Company PercayAI Partners with Canopy Biosciences to Accelerate Drug Development
EQ Staff, Jonathan Allen
November 26, 2019
October 4, 2021
< 1
Min
Read
Kingdom Capital Collaborates with Washington University School of Medicine to Launch Augmented Intelligence Company PercayAI
EQ Staff, Jonathan Allen
November 25, 2019
October 4, 2021
2
Min
Read
EQ